AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of GBP 253.76 billion. The enterprise value is 306.29 billion.

Market Cap	253.76B
Enterprise Value	306.29B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Jan 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 66.94.

PE Ratio	66.94
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.41, with an EV/FCF ratio of 26.28.

EV / Earnings	80.79
EV / Sales	6.73
EV / EBITDA	14.41
EV / EBIT	21.63
EV / FCF	26.28

Financial Position

The company has a current ratio of 0.65, with a Debt / Equity ratio of 11.75.

Current Ratio	0.65
Quick Ratio	0.44
Debt / Equity	11.75
Debt / EBITDA	2.75
Debt / FCF	4.57
Interest Coverage	6.47

Financial Efficiency

Return on equity (ROE) is 56.41% and return on invested capital (ROIC) is 14.32%.

Return on Equity (ROE)	56.41%
Return on Assets (ROA)	7.72%
Return on Capital (ROIC)	14.32%
Revenue Per Employee	828,663
Profits Per Employee	75,819
Employee Count	50,000
Asset Turnover	0.40
Inventory Turnover	3.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.59% in the last 52 weeks. The beta is 0.61, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	+7.59%
50-Day Moving Average	179.62
200-Day Moving Average	178.73
Relative Strength Index (RSI)	42.21
Average Volume (20 Days)	10,736

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.68

Income Statement

In the last 12 months, AbbVie had revenue of GBP 41.43 billion and earned 3.79 billion in profits. Earnings per share was 2.14.

Revenue	41.43B
Gross Profit	29.14B
Operating Income	12.89B
Pretax Income	5.37B
Net Income	3.79B
EBITDA	19.12B
EBIT	12.89B
Earnings Per Share (EPS)	2.14

Full Income Statement

Balance Sheet

The company has 5.44 billion in cash and 53.21 billion in debt, giving a net cash position of -47.78 billion.

Cash & Cash Equivalents	5.44B
Total Debt	53.21B
Net Cash	-47.78B
Net Cash Per Share	n/a
Equity (Book Value)	4.53B
Book Value Per Share	2.55
Working Capital	-11.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.32 billion and capital expenditures -662.54 million, giving a free cash flow of 11.66 billion.

Operating Cash Flow	12.32B
Capital Expenditures	-662.54M
Free Cash Flow	11.66B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.33%, with operating and profit margins of 31.10% and 9.22%.

Gross Margin	70.33%
Operating Margin	31.10%
Pretax Margin	12.96%
Profit Margin	9.22%
EBITDA Margin	46.15%
EBIT Margin	31.10%
FCF Margin	28.13%

Dividends & Yields

This stock pays an annual dividend of 4.84, which amounts to a dividend yield of 2.77%.

Dividend Per Share	4.84
Dividend Yield	2.77%
Dividend Growth (YoY)	2.06%
Years of Dividend Growth	10
Payout Ratio	212.79%
Buyback Yield	0.07%
Shareholder Yield	2.84%
Earnings Yield	1.50%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 1.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	n/a